(Q24658546)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

title

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1

Christian Prünte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

5

Katja Hatz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Franck Fajnkuchen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Sajjad Mahmood

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Federico Ricci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Vladimir Bezlyak

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Soumil Parikh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

William John Stubbings

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Andreas Wenzel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

João Figueira

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

RETAIN Study Group

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

language of work or name

English

0 references

publication date

9 October 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Ophthalmology

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

787-795

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.

26 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893084

Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893084

Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893084

Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893084

Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893084

Diabetes mellitus and the heart

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893084

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893084

Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893084

Burden of illness of diabetic macular edema: literature review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893084

Diabetic macular edema: pathogenesis and treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893084

28 September 2017

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2015-307249

A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2015-307249

A graphical approach to sequentially rejective multiple test procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2015-307249

Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2015-307249

ANTI-VEGF TREATMENT IN NEOVASCULAR AGE–RELATED MACULAR DEGENERATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2015-307249

Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol

21 January 2018

1 reference

12 December 2020

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema

1 reference

12 December 2020

A 12-month prospective trial of inject and extend regimen for ranibizumab treatment of age-related macular degeneration

1 reference

12 December 2020

Inject and extend dosing versus dosing as needed: a comparative retrospective study of ranibizumab in exudative age-related macular degeneration

1 reference

12 December 2020

Ranibizumab according to need: a treatment for age-related macular degeneration

1 reference

12 December 2020

Treatment outcomes after 3 years in neovascular age-related macular degeneration using a treat-and-extend regimen

1 reference

12 December 2020

Visual impairment in diabetes

1 reference

12 December 2020

10.1136/BJOPHTHALMOL-2015-307249

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

798037

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

OpenCitations bibliographic resource ID

26 February 2020

798037

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26453639%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

PubMed publication ID

26453639

1 reference